Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Umbilical Cord Blood for ASD in Children
NCT04243382Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2020
- Primary completion
- Dec 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood reinfusion in Autism Spectrum Disorder (ASD), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
autologous umbilical cord blood reinfusion
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04243382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04243382.